The use of pegylated liposomal doxorubicin (PLD) in association with weekly paclitaxel as second line therapy in metastatic bladder carcinoma: final results
- Authors: Albanese, GV; Pizzo, T; Galvano, A; Piazza, D; Macaluso, S; Provenzano, S; Badalamenti, G; Intrivici, C; Fulfaro, F; Gebbia, N
- Publication year: 2010
- Type: eedings
- Key words: bladder cancer,
- OA Link: http://hdl.handle.net/10447/58510